4R-tau strain-specific spreading patterns in PSP vs CBD

PARTIALLY ADDRESSED

PSP and CBD both involve 4R-tau but produce distinct neuropathological patterns (tufted astrocytes vs astrocytic plaques). Whether tau strains or regional cellular environments drive these differences is unresolved.

Priority: 0.87 Domain: neurodegeneration Hypotheses: 2
📊 Landscape Analysis

Landscape Summary: 4R-tau strain-specific spreading patterns in PSP vs CBD is a 0.87 priority gap in neurodegeneration. It has 2 linked hypotheses with average composite score 0.660. Status: partially_addressed.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

4R-tau strain-specific spreading patterns in PSP vs CBD — INVOKE-2 (completed)

📈 Living Dashboards
2
Hypotheses
0.682
Top Score
0.660
Avg Score
0
Debates
0.00
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)
Context-Dependent CRISPR Activation in Specific Neuronal Subtypes
Target: Cell-type-specific essential genes Pathway: CRISPRa transcriptional activa
0.682
score
Selective Neuronal Vulnerability Network Targeting
Target: Cell-type specific vulnerability markers Pathway: N/A
0.638
score
🌊 Knowledge Graph Connections

activates (5)

CBDmitochondrial dysfunctionCBDTRPV4PSPAgingPSPALSPSPAls

aggregates in (2)

tau_proteinPSPtau_proteinCBD

associated with (15)

PSPAlsPSPAlzheimerPSPAlzheimer's diseasePSPALZHEIMER'S DISEASEPSPParkinson's disease
▸ Show 10 more

biomarker for (2)

4R-tauCBD4R-tauPSP

causes (1)

4r-tauCBD

describes (1)

therapeutics-section-209-glp-1-receptor-agonists-cbs-pspPSP

downregulates (1)

PSPSV2A

expressed in (5)

PSPneuronsPSPAmyotrophic Lateral SclerosisPSPDementiaPSPAlzheimerPSPAls

inhibits (3)

CBDamyloid-βPSPAlzheimerPSPCancer

interacts with (1)

CBDtemozolomide

participates in (2)

PSPunfolded protein responsePSPoxidative stress response

regulates (4)

MOBPPSPCBDtau proteinPSPParkinson's diseasePSPSTX6

targets (1)

PSPtauopathy

therapeutic target (4)

PSPTauopathyPSPAlzheimerPSPNeurodegenerationPSPAmyotrophic Lateral Sclerosis

treats (3)

CBDgliomaCBDAlzheimer's diseasePSPAls
🕑 Activity Feed
📈 Selective Neuronal Vulnerability Network Targeting score=0.638 2026-04-04T13:37
💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps